FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2013/05/003707 [Registered on: 30/05/2013] Trial Registered Retrospectively
Last Modified On: 28/05/2013
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Nutraceutical 
Study Design  Non-randomized, Placebo Controlled Trial 
Public Title of Study   To see the serum lipid profile after using the Canola oil 
Scientific Title of Study   Effect of Canola oil consumption on the serum lipid profile of dyslipidemic adults- A Study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shradha Chauhan 
Designation  Research Scolar 
Affiliation  Max Healthcare Institute Limited  
Address  2 press enclave road max health care saket
2 press enclave road max health care saket
South
DELHI
110017
India 
Phone  09999918483  
Fax    
Email  shraddha.phd11@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bani Tamber Aeri 
Designation  Assistant professor 
Affiliation  Institute of home economics 
Address  Department of foods and nutrition Institute of home economics F-4 hauz khas
F-4 hauz khas
South
DELHI
110016
India 
Phone  09810271147  
Fax    
Email  baniaeri@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Shradha Chauhan 
Designation  Research Scolar 
Affiliation  Max Healthcare Institute Limited  
Address  2 press enclave road max health care saket
2 press enclave road max health care saket

DELHI
110017
India 
Phone  09999918483  
Fax    
Email  shraddha.phd11@gmail.com  
 
Source of Monetary or Material Support  
Max Healthcare  
 
Primary Sponsor  
Name  Max Super Specialty Hospital 
Address  2 press enclave road 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
Not Applicable  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Viveka kumar  Max Devki devi foundation Hospital  service floor , dept- cardiology
South
DELHI 
9871001190

viveka.kumar@maxhealthcare.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  CVD and CHD patients,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  canola oil  A group of dyslipidemic adults who will be provided with canola oil for their consumption during the intervention period along with dietary and lifestyle modification advice. 3 moths period to give the canola oil  
Comparator Agent  Not using canola oil  A group of dyslipidemic adults who will NOT be provided with any oil to be consumed during the intervention period. However, they will be given advice on dietary and lifestyle modification as in the experimental group.  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  All the individuals need to fulfill the certain criteria in order to be considered for enrollment. The following will serve as the inclusion criteria for the purpose
• Individuals having Total cholesterol >200mg/dl and/or LDL-cholesterol >130mg/dl
and/or triglycerides > 150mg/dl and/or HDL <40 mg/dl.
• Willingness to participate.
• Dyslipidemic adults not on lipid lowering drugs. Discussions with practicing cardiologists establish that the dyslipidemic patients are prescribed statins only on the basis of a combination of certain risk factors. For this, lipoproteins levels in the “high” level as prescribed by the NCEP- ATP III report (Table 2) are considered the cut-off beyond which statins are prescribed. Before statins are prescribed, the patients are advised to follow dietary and lifestyle modifications for about 4-6 months. Such patients will be the subjects of the study.
 
 
ExclusionCriteria 
Details  The following are the exclusion criteria:
• Those with liver disease, kidney disease, diabetes, CHD or malignancy.
• Pregnant women.
• Those on lipid lowering drug.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To find out the extent of change in the lipid profile levels of dyslipidemic adults post intervention.
 
3 months 
 
Secondary Outcome  
Outcome  TimePoints 
To find out the relationship of confounding factors (weight, waist circumference, stress) with lipid levels.   3 months 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/01/2013 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   after completion of study 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

1. Study objectives

 

1.1 Primary Objective

To assess the impact of consumption of canola oil in regular diet on the serum lipid profile of dyslipidemic adults.

1.2 Secondary Objectives

Secondary objectives of the study would be:

 

1.      To gather data on the existing dietary practices and food preferences of the target population.

2.      To collect data on height, weight, waist circumference and blood pressure of the participants.

3.      To do a cost benefit analysis of canola oil intake in terms of its lipid lowering effect.

 

These objectives will help in the establishment of the relationship of other confounding factors with dyslipidemia. For instance, the pattern of waist circumference measurements with the prevalence of dyslipidemia among individuals or the pattern of diet being followed amongst individuals who have high cholesterol levels etc.

 

 

2. Outcomes

 

2.1.1        Primary outcome 

To find out the extent of change in the lipid profile levels of dyslipidemic adults post intervention.

 

2.1.2        Secondary outcomes 

 

To find out the relationship of confounding factors (weight, waist circumference, stress) with lipid levels.

 

3. methodology:

 

As stated before, the study is a comparative control pre test post test design prospective study. Other details are specified below:

 

Study location: The study is proposed to be a hospital based study. This will allow the ease of data collection that is mainly dependent on biochemical testing. Subjects would be selected from the Preventive Health Check up (PHC) programs carried out at the hospitals on a regular basis. Verbal permission from the concerned authorities of a private hospital has already been obtained.

 

Participants: The participants of the research will be selected on the basis of their current lipoprotein levels as indicated by the health check up reports. Subjects would be dyslipidemic males and females within the age group of 20-55 years.

All the eligible participants will be included in the study only after clearly stating the aim, purpose and the motive of the study. At the end of it, only those who give an informed consent to participate in the study will be selected. Ethical clearance will also be sought from the concerned authorities.

The participants fulfilling the criteria of inclusion shall be considered for the intervention study. All the selected subjects will be randomly divided into 2 groups on the basis of age and gender matching- experimental group and control group (It is assumed that the subjects will be of the same demographic profile i.e. having same SES and lifestyle).

 

The study would be carried out in three phases. The proposed procedure of the research is explained below:

 

PHASE I: Pre - intervention Phase-

Selection of the sample:

The subjects (dyslipidemic adults) will be selected on the basis of the criteria discussed further They will be randomized  into two groups- experimental and control. The grouping will be as follows:

·         Experimental group: A group of dyslipidemic adults who will be provided with canola oil for their consumption during the intervention period along with dietary and lifestyle modification advice.

·         Control group: A group of dyslipidemic adults who will NOT be provided with any oil to be consumed during the intervention period. However, they will be given advice on dietary and lifestyle modification as in the experimental group.

 

Baseline data collection:

The baseline data will be collected through instruments such as the questionnaire, dietary recall, anthropometric measurements, blood pressure, energy expenditure calculation and also the biochemical tests.

 

Run –in period:

This will be followed by a run-in period of a month wherein the subjects in both the groups will be told to follow the diet and lifestyle modifications as advised to them at the time of enrolment. At the end of the run-in period, re-assessment of the lipoprotein levels would be done. The intervention would commence only at the end of the run-in period.

 

PHASE II: Intervention Phase-

Experimental Group:

All the subjects will be given a 3 month supply of oil. Although, initially, it was planned that the supply would be only for the subjects of the study, it was felt that it would not be very practical to prepare food separately specially vegetables and curry preparations (although, baghars can be done for the subject separately). This might cause inconvenience to the family which may further lead to a higher dropout rate. Hence, it is proposed that the oil will be supplied for the consumption of the family as well. Initially, 2 litres of oil in proper vacuum packaging to ensure purity and authenticity will be provided on a monthly basis. Further on the basis of the requirement of the subjects/subjects’ family, additional amount of oil may also be given. Although, this amount will be given to be used by the whole family for the stipulated period, the subjects will be encouraged  and instructed to ensure that the subjects consume only the intended oil and no other oil. However, other family members can include any other oil in their diet, if they want to. Regular compliance will be ensured to arrive at valid results. The subjects would be provided with a compliance checklist in which they would record any events of deviation from the suggested dietary guidelines e.g. eating out, entertaining guests etc.

Canola oil will be procured in vacuum packed bottles manufactured for the purpose of consumption from Dalmia Continental Pvt. Limited. The company has agreed to sponsor the required amount of the oil.

Along with the oil substitution, the subjects will be given advice on dietary and lifestyle modification to be followed in the consequent intervention period.

 

Control group:

The control group will be given appropriate advice on dietary and lifestyle modifications to be followed in the 3 month intervention period. They would be given information about healthy food choices and cooking practices (within their current consumption patterns) though, they will not be given any oil for consumption.

Both the groups will be provided with appropriate material (pamphlets/leaflets) for advice on dietary and lifestyle modification.

 

PHASE III: Post Intervention Phase-

After the completion of the intervention period, re collection of the data on the same grounds as the baseline data for both the groups will be carried out. This will help to study the impact of substituting canola oil in the daily dietary intake with dietary and lifestyle modifications in the experimental group (if any) vis a vis the effect of modifying the existing framework of dietary intake with dietary and lifestyle modifications in the control group (Fig 1). The analysis would highlight the extent of change in the lipid profile (if any) after the consumption of canola oil and thereby ascertain if the high cost of canola oil is justified.

 

As far as the collection of data is concerned, it would be ensured that there is a uniformity and consistency in the way the data is collected. The same equipments will be sued for measurements such as height, weight, waist circumference etc. wherever applicable, they will be calibrated periodically to ensure accuracy. In case of biochemical reports which are the mainstay of the study, it will be ensured that all three of the lipid profile tests are done from the same lab to rule out any change of standards.

 

 
Close